久操视频网站,又大又粗又黄又刺激的免费视频,亚洲三级电影在线播放,国产亚洲视频在线观看二区

中文
中文

以患者需求為核心,驅動細胞免疫治療創(chuàng)新,實現(xiàn)癌癥可控化并最終治愈。

We strive to make patients-driven cellular immunotherapy innovation, to transform cancer into a manageable condition — and ultimately cure it.

2023
  • 0
A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing data
. 2023 Oct 5;9(11):e20708. doi: 10.1016/j.heliyon.2023.e20708
Du Z, Zhang T, Lin Y, Dong G, Li A, Wang Z, Zhang Y, Giamas G, Stebbing J, Zhu L, Peng L.

Identification of a Novel Prognostic Signature Based on N-Linked Glycosylation and Its Correlation with Immunotherapy Response in Hepatocellular Carcinoma
. 2023 Oct 9;10:1749–1765. doi: 10.2147/JHC.S417407
Lin S, Cao Y, Zhu K, Yang C, Zhu X, Zhang H, Zhang R.



  • 上一篇:--
  • 下一篇:2021
04.16
2025
來源:
關鍵詞:
相關閱讀

Copyright ? 2019 天科雅生物醫(yī)藥科技有限公司

粵公網安備 44011502000528號

粵ICP備20056630號 Powered by vancheer
關于天科雅
研究與發(fā)展
產品及臨床
新聞與媒體

Copyright ? 2019 天科雅生物醫(yī)藥科技有限公司

粵公網安備 44011502000528號

粵ICP備20056630號 Powered by vancheer